[Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].

Source:http://linkedlifedata.com/resource/pubmed/id/21566438

Download in:

View as

General Info

PMID
21566438